Study to Assess the Long-term Safety, Tolerability, and Efficacy of AMG 827 in Subjects With Psoriasis

Stopped early · Phase 2

Conditions studied: Psoriasis

In brief

This study is an open-label extension of study 20090062 to evaluate extended subcutaneous dosing.

Key facts

Study ID

NCT01101100

Run by

Bausch Health Americas, Inc.

People needed

181

Starts

2010-04-01

Expected to finish

2015-09-01

Last updated by the study team

2019-07-30

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subject was randomized into Study 20090062 and completed the week 16 evaluation.

You may not qualify if…

• Subject had any Serious Adverse Event (SAE) reported during Study 20090062 that was considered possibly related to IP.
• Subject experienced an adverse event in Study 20090062 that, in the opinion of the investigator, could cause extension of treatment to be detrimental to the subject.

Where it is running

• Research Site — Newnan, Georgia, United States
• Research Site — Skokie, Illinois, United States
• Research Site — St Louis, Missouri, United States
• Research Site — Albuquerque, New Mexico, United States
• Research Site — Dallas, Texas, United States
• Research Site — Webster, Texas, United States
• Research Site — Kogarah, New South Wales, Australia
• Research Site — Adelaide, South Australia, Australia
• Research Site — Parkville, Victoria, Australia
• Research Site — Prahran, Victoria, Australia
• Research Site — Hamilton, Ontario, Canada
• Research Site — London, Ontario, Canada
• Research Site — Markham, Ontario, Canada
• Research Site — Waterloo, Ontario, Canada
• Research Site — Windsor, Ontario, Canada
• Research Site — Québec, Quebec, Canada
• Research Site — Aarhus, Denmark
• Research Site — Hellerup, Denmark
• Research Site — Besançon, France
• Research Site — Nice, France
• Research Site — Toulouse, France

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.